Do you want to link to this Amgen Site outside the UK and leave amgeninflammation.co.uk?
YOU ARE NOW LEAVING THIS WEBSITE. Amgen Limited and Amgen Ireland Limited takes no responsibility for, and exercises no control over, the organizations, views, or accuracy of the information contained on this server or site.
Full name: Interleukin-23
Aliases: IL-23A, P19, SGRF, and IL23P191
Size: ~59 kDa; heterodimeric cytokine composed of IL-12B (IL-12 p40) and IL-23A (IL-23 p19)1,2
Family: IL-12 family (IL-12, IL-23, IL-27, and IL-35)3
Receptors: IL-23R2
Major cellular sources: Phagocytic cells, macrophages, and activated DCs from peripheral tissues, including the skin, intestinal mucosa, and lungs2
Major cellular targets: T cells, Th17 cells, NK cells, NKT cells, eosinophils, monocytes, macrophages, DCs, and epithelial cells2
Disease states associated with: Psoriasis and organ-specific autoimmune diseases2
Major physiologic functions:
DC: dendritic cell; GM-CSF: granulocyte-macrophage colony-stimulating factor; IL: interleukin; IL-23R: IL-23 receptor; ILC: innate lymphoid cell; NK: natural killer; NKT: natural killer T; Th17: type 17 T helper.
Adverse events should be reported. Reporting forms and information can be found for the UK at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store, or for Ireland at https://www.hpra.ie/homepage/about-us/report-an-issue. Adverse events and product complaints should also be reported to Amgen Limited on +44 (0)1223 436441 (UK and Northern Ireland) or Freephone 1800 535 160 (Ireland)